Status: retired, Primitive. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1193586012 | Papaveretum+hyoscine hydrobromide (product) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 2695782018 | Hyoscine hydrobromide + Papaveretum | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 3525396016 | Product containing papaveretum and scopolamine hydrobromide (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3525397013 | Product containing papaveretum and scopolamine hydrobromide | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3525398015 | Papaveretum and scopolamine hydrobromide | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3525399011 | Hyoscine hydrobromide and papaveretum | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3525498019 | Product containing hyoscine hydrobromide and papaveretum | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3666453017 | Hyoscine hydrobromide and papaveretum product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3666454011 | Papaveretum and scopolamine hydrobromide product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 470743011 | Papaveretum+hyoscine hydrobromide | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 724715015 | Papaveretum+hyoscine hydrobromide (substance) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Hyoscine hydrobromide and papaveretum product | Is a | Papaveretum-containing product | false | Inferred relationship | Some | ||
| Hyoscine hydrobromide and papaveretum product | Has active ingredient | Opium preparation | false | Inferred relationship | Some | ||
| Hyoscine hydrobromide and papaveretum product | Has active ingredient | Papaveretum | false | Inferred relationship | Some | ||
| Hyoscine hydrobromide and papaveretum product | Has active ingredient | Central nervous system agent | false | Inferred relationship | Some | ||
| Hyoscine hydrobromide and papaveretum product | Has active ingredient | Opium | false | Inferred relationship | Some | ||
| Hyoscine hydrobromide and papaveretum product | Is a | Hyoscine hydrobromide | false | Inferred relationship | Some | ||
| Hyoscine hydrobromide and papaveretum product | Has active ingredient | Hyoscine hydrobromide | false | Inferred relationship | Some | ||
| Hyoscine hydrobromide and papaveretum product | Is a | Hyoscine hydrobromide | false | Inferred relationship | Some | ||
| Hyoscine hydrobromide and papaveretum product | Is a | Hyoscine-containing product in parenteral dose form | false | Inferred relationship | Some | ||
| Hyoscine hydrobromide and papaveretum product | Has manufactured dose form | Parenteral dose form | false | Inferred relationship | Some | ||
| Hyoscine hydrobromide and papaveretum product | Is a | Hyoscine-containing product | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Papaveretum 15.4mg/hyoscine 400mcg injection solution 1mL ampoule | Is a | False | Hyoscine hydrobromide and papaveretum product | Inferred relationship | Some | |
| Hyoscine hydrobromide 400 microgram/mL and papaveretum 15.4 mg/mL solution for injection ampoule | Is a | False | Hyoscine hydrobromide and papaveretum product | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
Description inactivation indicator reference set